Warning: The NCBI web site requires JavaScript to function. more...
Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.
Schoepflin S, Marfurt J, Goroti M, Baisor M, Mueller I, Felger I.
Malar J. 2008 May 6;7:78.
Related citations
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
Malar J. 2008 Jul 1;7:115.
Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.
Eshetu T, Berens-Riha N, Fekadu S, Tadesse Z, Gürkov R, Hölscher M, Löscher T, Miranda IB.
Malar J. 2010 Aug 7;9:226.
Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.
Ibrahim ML, Steenkeste N, Khim N, Adam HH, Konaté L, Coppée JY, Ariey F, Duchemin JB.
Malar J. 2009 Feb 23;8:32.
Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
Mkulama MA, Chishimba S, Sikalima J, Rouse P, Thuma PE, Mharakurwa S.
Malar J. 2008 May 21;7:87.
Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.
de Almeida A, Arez AP, Cravo PV, do Rosário VE.
Malar J. 2009 Apr 9;8:59.
Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea.
Nsanzabana C, Hastings IM, Marfurt J, Müller I, Baea K, Rare L, Schapira A, Felger I, Betschart B, Smith TA, Beck HP, Genton B.
J Infect Dis. 2010 Feb 1;201(3):435-43.
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.
Ferreira ID, Lopes D, Martinelli A, Ferreira C, do Rosário VE, Cravo P.
Trop Med Int Health. 2007 Mar;12(3):353-62.
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ.
Antimicrob Agents Chemother. 2007 Aug;51(8):3023-5. Epub 2007 Jun 11.
Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Fernandes N, Figueiredo P, do Rosário VE, Cravo P.
Malar J. 2007 Mar 23;6:35.
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
Sisowath C, Strömberg J, Mårtensson A, Msellem M, Obondo C, Björkman A, Gil JP.
J Infect Dis. 2005 Mar 15;191(6):1014-7. Epub 2005 Feb 8.
Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.
Malar J. 2006 Oct 4;5:82.
The risk of malarial infections and disease in Papua New Guinean children.
Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I.
Am J Trop Med Hyg. 2007 Jun;76(6):997-1008.
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
Ferreira ID, Martinelli A, Rodrigues LA, do Carmo EL, do Rosário VE, Póvoa MM, Cravo P.
Trop Med Int Health. 2008 Feb;13(2):199-207.
Chloroquine-resistant haplotype Plasmodium falciparum parasites, Haiti.
Londono BL, Eisele TP, Keating J, Bennett A, Chattopadhyay C, Heyliger G, Mack B, Rawson I, Vely JF, Désinor O, Krogstad DJ.
Emerg Infect Dis. 2009 May;15(5):735-40.
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M.
Malar J. 2007 Mar 9;6:28.
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Trotta RF, Brown ML, Terrell JC, Geyer JA.
Biochemistry. 2004 May 4;43(17):4885-91.
[Combination therapy as a strategy to prevent antimalarial drug resistance].
Orjuela P, González I, Osorio L.
Biomedica. 2004 Dec;24(4):423-37. Review. Spanish.
Quinolines and artemisinin: chemistry, biology and history.
Bray PG, Ward SA, O'Neill PM.
Curr Top Microbiol Immunol. 2005;295:3-38. Review.
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.
Ittarat W, Pickard AL, Rattanasinganchan P, Wilairatana P, Looareesuwan S, Emery K, Low J, Udomsangpetch R, Meshnick SR.
Am J Trop Med Hyg. 2003 Feb;68(2):147-52.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on